Page last updated: 2024-09-04

gadolinium dtpa and 5-carboxytetramethylrhodamine succinimidyl ester

gadolinium dtpa has been researched along with 5-carboxytetramethylrhodamine succinimidyl ester in 1 studies

Compound Research Comparison

Studies
(gadolinium dtpa)
Trials
(gadolinium dtpa)
Recent Studies (post-2010)
(gadolinium dtpa)
Studies
(5-carboxytetramethylrhodamine succinimidyl ester)
Trials
(5-carboxytetramethylrhodamine succinimidyl ester)
Recent Studies (post-2010) (5-carboxytetramethylrhodamine succinimidyl ester)
12,6546644,0511850112

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blasig, IE; Blasig, R; Deli, MA; Dithmer, S; Fallier-Becker, P; Gehne, N; Haseloff, RF; Kittel, Á; Ku, MC; Müller, C; Niendorf, T; Pohlmann, A; Staat, C; Veszelka, S; Walter, FR; Winkler, L1

Other Studies

1 other study(ies) available for gadolinium dtpa and 5-carboxytetramethylrhodamine succinimidyl ester

ArticleYear
Claudin peptidomimetics modulate tissue barriers for enhanced drug delivery.
    Annals of the New York Academy of Sciences, 2017, Volume: 1397, Issue:1

    Topics: Animals; Antibiotics, Antineoplastic; Blood-Brain Barrier; Brain; Cell Line; Cells, Cultured; Circular Dichroism; Claudin-5; Doxorubicin; Drug Delivery Systems; Endothelial Cells; Gadolinium DTPA; HEK293 Cells; Humans; Mice, Inbred C57BL; Microscopy, Confocal; Microscopy, Electron; Models, Molecular; Peptidomimetics; Permeability; Protein Conformation; Rats; Rhodamines; Tight Junctions; Time-Lapse Imaging

2017